Recent advances in pharmacological treatment of heart failure

BACKGROUND: Over the last years, several trials offered new evidence on heart failure (HF) treatment. DESIGN AND RESULTS: For HF with reduced left ventricular ejection fraction, type 2 sodium—glucose cotransporter inhibitors, aside from sacubitril—valsartan, demonstrated extraordinary efficacy in am...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacoviello, Massimo, Palazzuoli, Alberto, Gronda, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596398/
https://www.ncbi.nlm.nih.gov/pubmed/34043809
http://dx.doi.org/10.1111/eci.13624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596398/
https://www.ncbi.nlm.nih.gov/pubmed/34043809
http://dx.doi.org/10.1111/eci.13624

Ejemplares similares